Clinical Trials Directory

Trials / Completed

CompletedNCT04043000

Super 13 Pro & Prebiotics on the Human Intestinal Microflora

Effects of Super 13 Pro & Prebiotics on the Human Intestinal Microflora: a Double-blind, Randomized, Placebo-controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Cheng-Hsin General Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study aim to investigate the roles of the test article in improving gastrointestinal functions and gut microbiota of humans. A total 40 healthy adults were recruited and randomly divided into experimental and control groups, with 20 subjects each, for a 4-week trial. The subjects took the test article, "Super 13 Pro \& Prebiotics" or the control article, "The placebo without Super 13 Pro \& Prebiotics" during the 4-week drug-intake period. Fecal specimens were collected at the 0th, 2nd, and 4th weeks of the trial for analyzing the bacterial counts of Bifidobacterium spp., Clostridium perfringens, Lactobacillus spp., and Coliform.

Detailed description

This study aim to investigate the roles of the test article in improving gastrointestinal functions and gut microbiota of humans. A total 40 healthy adults were recruited and randomly divided into experimental and control groups, with 20 subjects each, for a 4-week trial. The subjects took the test article, "Super 13 Pro \& Prebiotics" or the control article, "The placebo without Super 13 Pro \& Prebiotics" three times a day during the 4-week drug-intake period. Fecal specimens were collected at the 0th, 2nd, and 4th weeks of the trial for analyzing the bacterial counts of Bifidobacterium spp., Clostridium perfringens, Lactobacillus spp., and Coliform.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSuper 13 Pro & Prebiotics"Super 13 Pro \& Prebiotics" was given three times a day for four weeks.

Timeline

Start date
2019-10-21
Primary completion
2019-11-18
Completion
2019-11-18
First posted
2019-08-02
Last updated
2020-07-10

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04043000. Inclusion in this directory is not an endorsement.